Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 44
Inquire Before Buying

GlobalData's clinical trial report, "Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2016" provides an overview of Fibrinogen Deficiency (Factor I Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months


Reasons to buy


  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 41
Abbreviations 41
Definitions 41
Research Methodology 42
Secondary Research 42
About GlobalData 43
Contact Us 43
Disclaimer 43
Source 44

List of Tables

Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 15
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 19
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2016* 22
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31

List of Figures

Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 10
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 18
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 42

  • Global Clinical Trial Supplies Market Size, Status and Forecast 2022
    Published: 05-Oct-2017        Price: US 3300 Onwards        Pages: 94
    This report studies the global Clinical Trial Supplies market, analyzes and researches the Clinical Trial Supplies development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Alamc Group - Catalent Pharma Solutions - KLIFO A/S - Movianto - PCI Services - Patheon - PAREXEL International - Sharp Packaging Services - Biocair - Thermo......
  • Global Clinical Trials Market Size, Status and Forecast 2022
    Published: 14-Sep-2017        Price: US 3300 Onwards        Pages: 98
    This report studies the global Clinical Trials market, analyzes and researches the Clinical Trials development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Quintiles IMS Holdings - LabCorp (Covance Inc.) - Pharmaceutical Product Development (PPD) - Parexel International Corporation - ICON - INC Research - inVentiv Health - PRA Health......
  • Heart Transplant Rejection Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 118
    Heart Transplant Rejection Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Heart Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Heart Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Heart Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the glo......
  • Heart Valve Disease Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 136
    Heart Valve Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Heart Valve Disease Global Clinical Trials Review, H2, 2017" provides an overview of Heart Valve Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Heart Valve Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers covera......
  • Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 314
    Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Helicobacter pylori Infections Global Clinical Trials Review, H2, 2017" provides an overview of Helicobacter pylori Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducte......
  • Helminthiasis Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 52
    Helminthiasis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Helminthiasis Global Clinical Trials Review, H2, 2017" provides an overview of Helminthiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Helminthiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical t......
  • Helminthic Infestations Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 45
    Helminthic Infestations Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Helminthic Infestations Global Clinical Trials Review, H2, 2017" provides an overview of Helminthic Infestations clinical trials scenario. This report provides top line data relating to the clinical trials on Helminthic Infestations. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The repo......
  • Hemangiomas Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 79
    Hemangiomas Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemangiomas Global Clinical Trials Review, H2, 2017" provides an overview of Hemangiomas clinical trials scenario. This report provides top line data relating to the clinical trials on Hemangiomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by......
  • Hematological Tumor Global Clinical Trials Review, H2, 2017
    Published: 01-Sep-2017        Price: US 2500 Onwards        Pages: 247
    Hematological Tumor Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hematological Tumor Global Clinical Trials Review, H2, 2017" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers covera......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs